Advising the Startup II

Catalog description

This course is the second part of a two part year-long sequence on legal issues arising from start-up companies as they develop and move towards an initial public offering. This second part covers the legal issues arising from FDA approval for pharmaceuticals and medical devices, patent and antitrust issues arising from the market for generic pharmaceuticals, platform economies created by Apple, Google, and other tech companies, and the uses of legal technology, such as ChatGPT, in legal practice. The course is designed for students across disciplines (law, business, engineering, information science, public policy) who are interested in the legal foundations for start-ups and entrepreneurship. For JD students, pursuing LAW 815 and the Technology Commercialization track, the two-semester sequence of LAW 824 and LAW 825 replaces and expands upon the previous LAW 814 and is strongly recommended for LAW 815 and technology commercialization career. JD students seeking the certificate for the Technology Commercialization Law Program must take both LAW 824 and LAW 825 ; other students can take either or both semesters. Professional Writing credit or New York State Practice Credit is available for law students.